coldargan
sigmapharm arzneimittel gmbh & co kg - sidabro proteinatas/efedrino levulinatas/kalcio levulinatas - nosies lašai (tirpalas) - 25 mg/20 mg/2,2 mg/ml; 3,5 mg/2,8 mg/0,31 mg/išpurškime - combinations
metylprednisolon hikma
edupharma, uab - metilprednizolonas - milteliai injekciniam tirpalui - 250 mg - methylprednisolone
metylprednisolon hikma
edupharma, uab - metilprednizolonas - milteliai injekciniam tirpalui - 125 mg/5 ml; 1000 mg - methylprednisolone
easotic
virbac s.a. - gentamicin sulfate, hydrocortisone aceponate, miconazole nitrate - otologicals, kortikosteroidai ir antiinfectives kartu - Šunys - Ūmių otitis externa, ir ūmių paūmėjimo periodinio otitis externa, susijęs su bakterijų jautrūs gentamicino ir grybų jautrūs miconazole, ypač malassezia pachydermatis.
mycophenolate mofetil teva
teva pharma b.v. - mikofenolato mofetilis - dantų atmetimas - imunosupresantai - mikofenolato mofetilio teva skirtas vartoti kartu su ciklosporinu ir kortikosteroidais transplantato ūminio atmetimo profilaktikai pacientams, vartojantiems alogeninės inkstų, širdies ar kepenų transplantacijos.
myfenax
teva b.v. - mikofenolato mofetilis - dantų atmetimas - imunosupresantai - myfenax skiriama kartu su ciklosporinu ir kortikosteroidais transplantato ūminio atmetimo profilaktikai pacientams, vartojantiems alogeninės inkstų, širdies ar kepenų transplantacijos.
potactasol
actavis group ptc ehf - topotekanas - uterine cervical neoplasms; small cell lung carcinoma - antinavikiniai vaistai - topotecan monotherapy is indicated for the treatment of:- patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy- patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate (see section 5. topotecan kartu su cisplatina skiriamas pacientams su karcinomos, gimdos kaklelio periodinis po radioterapijos ir pacientams, sergantiems etape ivb ligos. patients with prior exposure to cisplatin require a sustained treatment free interval to justify treatment with the combination (see section 5.
ajovy
teva gmbh - fremanezumab - migrenos sutrikimai - calcitonin gene-related peptide (cgrp) antagonists - ajovy skiriama profilaktika migrena, suaugusiems žmonėms, kurie turi ne mažiau kaip 4 migrena dienas per mėnesį.
ranivisio
midas pharma gmbh - ranibizumabas - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologai - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
dimethyl fumarate teva
teva gmbh - dimetilfumaratas - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresantai - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).